1173 related articles for article (PubMed ID: 18571105)
1. Meningococcal disease: risk for international travellers and vaccine strategies.
Wilder-Smith A
Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal disease in international travel: vaccine strategies.
Wilder-Smith A
J Travel Med; 2005 Apr; 12 Suppl 1():S22-9. PubMed ID: 16225803
[TBL] [Abstract][Full Text] [Related]
3. Meningococcal vaccine in travelers.
Wilder-Smith A
Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal disease and prevention at the Hajj.
Borrow R
Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal disease.
Memish ZA; Alrajhi AA
Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal disease and travel.
Wilder-Smith A; Memish Z
Int J Antimicrob Agents; 2003 Feb; 21(2):102-6. PubMed ID: 12615371
[TBL] [Abstract][Full Text] [Related]
7. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
Zuckerman JN; Bröker M; Worth C
Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
[TBL] [Abstract][Full Text] [Related]
8. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
Khalil MK; Borrow R
Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
[TBL] [Abstract][Full Text] [Related]
9. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
Yezli S
Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal disease and travel.
Memish ZA
Clin Infect Dis; 2002 Jan; 34(1):84-90. PubMed ID: 11731951
[TBL] [Abstract][Full Text] [Related]
11. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.
Shibl A; Tufenkeji H; Khalil M; Memish Z;
East Mediterr Health J; 2013 Apr; 19(4):389-92. PubMed ID: 23882966
[TBL] [Abstract][Full Text] [Related]
12. [Meningococcal disease in Africa--epidemiology and prevention].
Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
[TBL] [Abstract][Full Text] [Related]
13. Optimizing protection against meningococcal disease.
Reisinger KS; Black S; Stoddard JJ
Clin Pediatr (Phila); 2010 Jun; 49(6):586-97. PubMed ID: 20089551
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
15. [Global spread of meningococcal serogroup W135].
Vestergård D; David KP
Ugeskr Laeger; 2008 Sep; 170(39):3044-7. PubMed ID: 18822228
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal vaccine against serogroups A, C, Y and W-135: new preparation. Encouraging immunogenicity studies.
Prescrire Int; 2002 Apr; 11(58):35-8. PubMed ID: 11987309
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal disease in travelers: update on vaccine options.
Cramer JP; Wilder-Smith A
Curr Opin Infect Dis; 2012 Oct; 25(5):507-17. PubMed ID: 22907278
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal vaccine evolution.
Bona G; Guidi C
J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
20. Challenges for development of meningococcal vaccines in infants and children.
Deasy A; Read RC
Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
